dual ROCK-1/2 inhibitors (Bristol Myers Squibb)

N/A

Report date: 2025/03/18 18:13:25
NME

Base Information

Drug Namedual ROCK-1/2 inhibitors (Bristol Myers Squibb)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitorsRho-associated protein kinase 1 inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A